Itwas statistically significant that vitamin D levels were lower in the oncology patients when compared with the controlgroup (p
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objectives: This study aimed to determine whether vitamin D levels differ between cancer patients and non-cancercontrol groups, to determine the differences between the reference values and also to determine the prevalence ofvitamin D deficiency in cancer patients.Methods: Vitamin D levels were examined retrospectively between 2017-2018 in outpatient oncology patients andnon-oncology patients who applied to Mardin State Hospital.Results: A total of 355 patients were examined (157 oncologic patient group and 198 in the control group).
📊
Key Findings & Data:The medianage of the oncologic patient group was 55.24 (19-85) and the control group was 55.45 (18-89).
💡
Conclusion & Impact:Itwas statistically significant that vitamin D levels were lower in the oncology patients when compared with the controlgroup (p
🔬Design:Research Article
📍Scope:2017-2018 Verileri
⚙️Variables:Domain Parameters
Abstract
Objectives: This study aimed to determine whether vitamin D levels differ between cancer patients and non-cancercontrol groups, to determine the differences between the reference values and also to determine the prevalence ofvitamin D deficiency in cancer patients.Methods: Vitamin D levels were examined retrospectively between 2017-2018 in outpatient oncology patients andnon-oncology patients who applied to Mardin State Hospital.Results: A total of 355 patients were examined (157 oncologic patient group and 198 in the control group). The medianage of the oncologic patient group was 55.24 (19-85) and the control group was 55.45 (18-89). The median vitamin Dvalue of the oncology patients was 8.15 ng / mL (≤4.2-33.72) and the control group was 14.39 ng / mL (≤4.2-60.13). Itwas statistically significant that vitamin D levels were lower in the oncology patients when compared with the controlgroup (p
🔖
Cite This Article
AYTEKİN, A. (2022). Comparison of Vitamin D Levels Between Healthy Individuals and Cancer Patients. Eurasian Journal of Medical Investigation, Cilt: 4 - Sayı: 2, 259–264. https://ajindex.com/articles/508649
Almeida LFd, Coimbra TM. Vitamin D actions on cell differentiation, proliferation and inflammation. International Journal of Complementary & Alternative Medicine 2017
[CrossRef ] 2. Zerwekh JE. Blood biomarkers of vitamin D status. The American journal of clinical nutrition 2008
1087S–91S. [CrossRef ] 3. Bikle DD. Vitamin D metabolism, mechanism of action, and clinical applications. Chemistry & biology 2014
319–29. 4. Clinckspoor I, Verlinden L, Mathieu C, Bouillon R, Verstuyf A, Decallonne B. Vitamin D in thyroid tumorigenesis and development. Progress in histochemistry and cytochemistry 2013
65–98. [CrossRef ] 5. LeBlanc ES, Zakher B, Daeges M, Pappas M, Chou R. Screening for vitamin D deficiency: a systematic review for the US Preventive Services Task Force. Annals of internal medicine 2015
109–22. [CrossRef ] 6. Peller S, Stephenson C. Skin irritation and cancer in the US Navy. The American Journal of the Medical Sciences 1937
326–33. [CrossRef ] 7. Apperly FL. The relation of solar radiation to cancer mortality in North America. Cancer Research 1941
191–5. 8. Chiang K-C, C Chen T. The anti-cancer actions of vitamin D. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents) 2013
126–39. 9. Feskanich D, Ma J, Fuchs CS, Kirkner GJ, Hankinson SE, Hollis BW, et al. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiology and Prevention Biomarkers 2004
1502–8. 10. Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. Journal of the National Cancer Institute 2006
451–9. [CrossRef ] 11. Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB, et al. The role of vitamin D in cancer prevention. American journal of public health 2006
252–61. [CrossRef ] 12. Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: a systematic review. The lancet Diabetes & endocrinology 2014
76–89. [CrossRef ] 13. Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ. The role of vitamin D in reducing cancer risk and progression. Nature reviews cancer 2014
[CrossRef ] 14. Kim Y, Je Y. Vitamin D intake, blood 25 (OH) D levels, and breast cancer risk or mortality: a meta-analysis. British journal of cancer 2014
[CrossRef ] 15. Dimitrakopoulou VI, Tsilidis KK, Haycock PC, Dimou NL, Al- Dabhani K, Martin RM, et al.